Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Wabash National
WNC
$491M
| $13.3M | 0.03% |
1,259,615
+508,570
| +68% | +$6.25M |
|
777
First Interstate BancSystem
FIBK
$3.55B
| $13.3M | 0.03% |
478,847
-314,473
| -40% | -$8.62M |
|
778
Expeditors International
EXPD
$24.4B
| $13.3M | 0.03% |
283,125
-283,306
| -50% | -$13.4M |
|
|
ALJ
779
DELISTED
Alon USA Energy Inc
ALJ
| $13.3M | 0.03% |
736,550
+613,532
| +499% | +$11.6M |
|
780
ManpowerGroup
MAN
$2.86B
| $13.3M | 0.03% |
162,354
+8,559
| +6% | +$762K |
|
|
SGMO
781
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $13.3M | 0.03% |
2,355,569
+1,589,904
| +208% | +$13.1M |
|
|
SEP
782
DELISTED
Spectra Engy Parters Lp
SEP
| $13.3M | 0.03% |
+330,142
| New | +$15.4M |
|
|
MMP
783
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $13.2M | 0.03% |
+220,000
| New | +$15M |
|
|
QEP
784
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $13.2M | 0.03% |
1,055,300
+843,700
| +399% | +$11.6M |
|
|
HAR
785
DELISTED
Harman International Industries
HAR
| $13.2M | 0.03% |
+137,403
| New | +$14.4M |
|
786
Baxter International
BAX
$13.7B
| $13.1M | 0.03% |
400,182
-440,444
| -52% | -$16.7M |
|
|
HT
787
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $13.1M | 0.03% |
578,794
-428,581
| -43% | -$10.9M |
|
788
Regions Financial
RF
$26.1B
| $13.1M | 0.03% |
1,455,242
-2,209,318
| -60% | -$21.8M |
|
|
PGNX
789
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $13M | 0.03% |
2,280,423
+275,897
| +14% | +$2.12M |
|
790
Enbridge
ENB
$109B
| $13M | 0.03% |
350,523
-470,500
| -57% | -$19.6M |
|
|
EDE
791
DELISTED
Empire District Electric
EDE
| $13M | 0.03% |
590,427
+38,829
| +7% | +$865K |
|
|
CLNY
792
DELISTED
Colony Capital, Inc.
CLNY
| $13M | 0.03% |
664,447
+423,252
| +175% | +$9.37M |
|
793
MSCI
MSCI
$41.5B
| $12.9M | 0.03% |
217,598
+40,539
| +23% | +$2.55M |
|
794
Allison Transmission
ALSN
$10.8B
| $12.9M | 0.02% |
482,545
-1,463,961
| -75% | -$41.9M |
|
795
Prothena Corp
PRTA
$482M
| $12.9M | 0.02% |
283,922
-255,991
| -47% | -$14.9M |
|
|
ARRS
796
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $12.8M | 0.02% |
494,696
-616,396
| -55% | -$17.5M |
|
|
HRC
797
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $12.8M | 0.02% |
246,429
-410,751
| -63% | -$22.2M |
|
798
Ironwood Pharmaceuticals
IRWD
$682M
| $12.8M | 0.02% |
1,466,525
+283,038
| +24% | +$2.64M |
|
799
ATI
ATI
$28.6B
| $12.8M | 0.02% |
899,525
+572,568
| +175% | +$11.9M |
|
|
CMA.WS
800
DELISTED
Comerica Incorporated Ws
CMA.WS
| $12.8M | 0.02% |
1,005,656
-46,700
| -4% | -$766K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.